内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Tilray Brands, Inc.

TLRY · Nasdaq · CIK 0001731348 · Healthcare · Drug Manufacturers—Specialty & Generic

内部人信号

当前没有活跃买入信号

3 qualifying P purchase groups
当前 180 天评分窗口

45 同一窗口内观察到的 Form 4 交易行
1 sales · 41 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-08-06 · Gendel Mitchell · $11.1K

为什么没有活跃信号？

买入活动存在
近期买入3 qualifying line group(s)
近期卖出较低
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Merton Carl AChief Financial Officer
○○○○●○○
Gendel MitchellGlobal General Counsel
○○○○●○○
FALTISCHEK DENISE MChief Strategy Officer
○○○○●○○
SIMON IRWIN DPresident and CEO
○○○○○○
Hopkinson David G.Director
▼○
Persofsky RenahDirector
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方3
买入集中度67%最大买方： Merton Carl A · $46.2K
聚集买入 · 15天3 insiders峰值活动： 2026-08-03–2026-08-06

Roles in the peak window: Chief Financial Officer, Chief Strategy Officer, Global General Counsel. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-08-06 · Gendel Mitchell.

近期 Form 4 活动

3买入
1卖出
42其他 Form 4 交易行
19SEC 申报 · 365天
买入3 qualifying P line(s) · 180 days
卖出1 sale line(s) · 仅供背景
其他41 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
18,790,909
上期报告
19,418,606
日均成交量
3,615,725
回补天数
5.2

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-08-06Gendel Mitchell买入 (P)Common Stock2,500USD 4.43USD 11,075SEC 申报 ↗
2026-08-04Merton Carl A买入 (P)Common Stock10,000USD 4.62USD 46,200SEC 申报 ↗
2026-08-03FALTISCHEK DENISE M买入 (P)Common Stock2,500USD 4.78USD 11,950SEC 申报 ↗
2025-07-31Gendel Mitchell买入 (P)Common Stock6,000USD 0.58USD 3,480SEC 申报 ↗
2025-07-30SIMON IRWIN D买入 (P)Common Stock165,000USD 0.61USD 100,650SEC 申报 ↗
2025-07-30Merton Carl A买入 (P)Common Stock33,500USD 0.60USD 20,100SEC 申报 ↗
2024-11-15Merton Carl A买入 (P)Common Stock26,000USD 1.36USD 35,360SEC 申报 ↗
2024-01-17FALTISCHEK DENISE M买入 (P)Common Stock10,000USD 2.05USD 20,500SEC 申报 ↗
2024-01-16Gendel Mitchell买入 (P)Common Stock7,200USD 1.98USD 14,256SEC 申报 ↗
2024-01-12SIMON IRWIN D买入 (P)Common Stock53,700USD 1.88USD 100,956SEC 申报 ↗
2024-01-12Merton Carl A买入 (P)Common Stock20,000USD 1.87USD 37,400SEC 申报 ↗
2024-01-12Gendel Mitchell买入 (P)Common Stock5,400USD 1.87USD 10,098SEC 申报 ↗

Form 4 申报证据

46 transaction lines in the latest 365-day window; 448 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-26SIMON IRWIN D期权行权／转换 (M)Common Stock1,212,168USD 0.00USD 0SEC 申报 ↗
2026-08-26SIMON IRWIN D代扣税 (F)Common Stock642,450USD 4.88USD 3,135,156SEC 申报 ↗
2026-08-26Merton Carl A期权行权／转换 (M)Common Stock168,452USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-26SIMON IRWIN D期权行权／转换 (M)Common Stock1,212,168USD 0.00USD 0SEC 申报 ↗
2026-08-26SIMON IRWIN D代扣税 (F)Common Stock642,450USD 4.88USD 3,135,156SEC 申报 ↗
2026-08-26Merton Carl A期权行权／转换 (M)Common Stock168,452USD 0.00USD 0SEC 申报 ↗
2026-08-26Merton Carl A代扣税 (F)Common Stock92,649USD 4.88USD 452,127SEC 申报 ↗
2026-08-26Gendel Mitchell期权行权／转换 (M)Common Stock160,304USD 0.00USD 0SEC 申报 ↗
2026-08-26Gendel Mitchell代扣税 (F)Common Stock84,962USD 4.88USD 414,615SEC 申报 ↗
2026-08-26FALTISCHEK DENISE M期权行权／转换 (M)Common Stock178,221USD 0.00USD 0SEC 申报 ↗
2026-08-26FALTISCHEK DENISE M代扣税 (F)Common Stock94,459USD 4.88USD 460,960SEC 申报 ↗
2026-08-06Gendel Mitchell买入 (P)Common Stock2,500USD 4.43USD 11,075SEC 申报 ↗
2026-08-04Merton Carl A买入 (P)Common Stock10,000USD 4.62USD 46,200SEC 申报 ↗
2026-08-03FALTISCHEK DENISE M买入 (P)Common Stock2,500USD 4.78USD 11,950SEC 申报 ↗
2026-07-30SIMON IRWIN D期权行权／转换 (M)Common Stock117,647USD 0.00USD 0SEC 申报 ↗
2026-07-30SIMON IRWIN D代扣税 (F)Common Stock62,353USD 4.20USD 261,883SEC 申报 ↗
2026-07-30Merton Carl A期权行权／转换 (M)Common Stock16,656USD 0.00USD 0SEC 申报 ↗
2026-07-30Merton Carl A代扣税 (F)Common Stock9,161USD 4.20USD 38,476SEC 申报 ↗
2026-07-30Gendel Mitchell期权行权／转换 (M)Common Stock24,379USD 0.00USD 0SEC 申报 ↗
2026-07-30Gendel Mitchell代扣税 (F)Common Stock12,921USD 4.20USD 54,268SEC 申报 ↗
2026-07-30FALTISCHEK DENISE M期权行权／转换 (M)Common Stock26,120USD 0.00USD 0SEC 申报 ↗
2026-07-30FALTISCHEK DENISE M代扣税 (F)Common Stock13,844USD 4.20USD 58,145SEC 申报 ↗
2026-07-29SIMON IRWIN D期权行权／转换 (M)Common Stock428,448USD 0.00USD 0SEC 申报 ↗
2026-07-29SIMON IRWIN D代扣税 (F)Common Stock227,078USD 3.99USD 906,041SEC 申报 ↗
2026-07-29Merton Carl A期权行权／转换 (M)Common Stock60,417USD 0.00USD 0SEC 申报 ↗
2026-07-29Merton Carl A代扣税 (F)Common Stock30,209USD 3.99USD 120,534SEC 申报 ↗
2026-07-29Gendel Mitchell期权行权／转换 (M)Common Stock87,440USD 0.00USD 0SEC 申报 ↗
2026-07-29Gendel Mitchell代扣税 (F)Common Stock46,344USD 3.99USD 184,913SEC 申报 ↗
2026-07-29FALTISCHEK DENISE M期权行权／转换 (M)Common Stock93,685USD 0.00USD 0SEC 申报 ↗
2026-07-29FALTISCHEK DENISE M代扣税 (F)Common Stock49,654USD 3.99USD 198,119SEC 申报 ↗
2026-07-29Persofsky Renah期权行权／转换 (M)Common Stock43,104USD 0.00USD 0SEC 申报 ↗
2026-07-29Persofsky Renah代扣税 (F)Common Stock21,552USD 3.99USD 85,992SEC 申报 ↗
2026-07-29Looney Thomas P.期权行权／转换 (M)Common Stock43,104USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码TLRY
CIK0001731348
行业Healthcare
细分行业Drug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2833 Medicinal Chemicals & Botanical Products
交易所Nasdaq

数据覆盖

本地 Form 4 历史448 transaction lines from 2020-01-01 to 2026-08-26
12 P purchase lines · 47 S sale lines · 389 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.